The information on this page is based on a number of underlying datasets, most of which are updated monthly. We maintain an update schedule which explains which version of each dataset we are currently relying on.
4 PENDINAS is a small flat of 53m², built sometime between 2007 and 2011, which could now be worth an estimated £129,033. It was last sold for £117,950 in September 2006, which was around 22% above the average September 2006 flat price in the Wrexham local authority area. The most recent EPC inspection was March 2021, where the current energy rating was C, and the potential energy rating was B.
Land registry data shows one sale for 4 PENDINAS since 1st January 1995. The below table shows the price paid for the one sale, along with the average flat price in the Wrexham local authority area for the corresponding sale date. The average price is sourced from the Office for National Statistics' House Price Index (HPI).
| Date | Price | HPI Price | Variation from HPI |
|---|---|---|---|
2006 29 SEP | £117,950 | £96,956 | 22% above HPI |
4 PENDINAS might now be worth an estimated £129,033.
This is based on house price inflation of 9.4%, between September 2006 and July 2026, for flats, in the Wrexham local authority area, as calculated by the Office for National Statistics and published in their UK House Price Index (HPI).
The 9.4% inflationary increase is applied to the most recent sale price for 4 PENDINAS of £117,950 on 29th September 2006. For the value to have increased from £117,950 to £129,033 over the twenty years and two months to July 2026, the following assumptions must hold true:
4 PENDINAS is 53m² according to the EPC inspection conducted in March 2021. This puts it in the smallest 40% of flats in Wrexham, based on EPC data. 36% of flats are smaller than 4 PENDINAS, and 61% of flats are larger. Note that EPC data is not available for all properties in Wrexham.
4 PENDINAS sits on a plot of roughly 0.418 of an acre, or 1,693m².
4 PENDINAS is located in WREXHAM, in the LL11 postcode district.
Most recent sales first: